The large new position by Norges Bank may signal long-term value recognition in TEVA's generics and specialty portfolio, while the exit by RenTech could reflect short-term risk-off behavior. Traders should monitor for follow-on buying from other value-oriented funds and watch for any shift in TEVA's restructuring or debt reduction progress.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 2 $33.76entry
- T+1 · 9mo ago −4.44%α −3.53% · $32.26
- T+5 · 8mo ago −6.69%α −5.48% · $31.50
- T+20 · 8mo ago −16.09%α −8.15% · $28.33
- T+60 · 6mo ago +2.53%α −6.80% · $34.61
How similar events traded
Executive Summary
In Q4 2025, a mixed institutional cluster emerged in Teva Pharmaceutical, with three major institutions adding $1.24B in net new positions, led by Norges Bank's $1.1B new entry, while two quant funds exited or trimmed holdings, resulting in $20.4M in net selling. The divergence suggests a split in institutional sentiment, with long-term sovereign and passive investors accumulating while high-frequency quant funds reduced exposure.
Key Financial Metrics
Institutional Positions
Net institutional flow: $1.2B
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Norges Bank | NEW | +0% | $1.1B | $1.1B |
| Morgan Stanley | ADD | +30.4% | $263.6M | $132.8M |
| Two Sigma | DOUBLED | +121% | $8.3M | $5.9M |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| RenTech | EXIT | -100% | $20.3M | -$20.3M |
| Duquesne | TRIM | -64.6% | $335.0K | -$151.8K |
Key Facts
- Norges Bank established a new $1.10B position in TEVA, the largest single buyer in the cluster.
- Morgan Stanley increased its stake by 30.4%, adding $132.8M in value.
- Two Sigma doubled its position despite small base size, signaling tactical conviction.
- RenTech fully exited its $20.3M position, indicating loss of confidence or strategy shift.
- Duquesne Family Office trimmed its stake by 64.6%, though the absolute value change was minimal ($152K).
Financial Impact
3 institutions accumulated $1.24B in new positions while 2 reduced holdings by $20.4M
Risk Factors
- Quant fund exits may indicate deteriorating technicals or model-driven de-risking.
- Low float impact from sellers means limited immediate downside pressure, but lack of broad institutional participation limits upside momentum.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-TEVA-2025-Q4 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers